Precidian Funds, Announces the Liquidation of AstraZeneca PLC ADRhedged
-
Surprise appointment Riera named Frankfurt coach
-
Maersk to take over Panama Canal port operations from HK firm
-
US arrests prominent journalist after Minneapolis protest coverage
-
Analysts say Kevin Warsh a safe choice for US Fed chair
-
Trump predicts Iran will seek deal to avoid US strikes
-
US oil giants say it's early days on potential Venezuela boom
-
Fela Kuti to be first African to get Grammys Lifetime Achievement Award
-
Trump says Iran wants deal, US 'armada' larger than in Venezuela raid
-
US Justice Dept releases new batch of documents, images, videos from Epstein files
-
Four memorable showdowns between Alcaraz and Djokovic
-
Russian figure skating prodigy Valieva set for comeback -- but not at Olympics
-
Barcelona midfielder Lopez agrees contract extension
-
Djokovic says 'keep writing me off' after beating Sinner in late-nighter
-
US Justice Dept releasing new batch of Epstein files
-
South Africa and Israel expel envoys in deepening feud
-
French eyewear maker in spotlight after presidential showing
-
Olympic dream 'not over', Vonn says after crash
-
Brazil's Lula discharged after cataract surgery
-
US Senate races to limit shutdown fallout as Trump-backed deal stalls
-
'He probably would've survived': Iran targeting hospitals in crackdown
-
Djokovic stuns Sinner to set up Australian Open final with Alcaraz
-
Mateta omitted from Palace squad to face Forest
-
Gold, silver prices tumble as investors soothed by Trump's Fed pick
-
Trump attorney general orders arrest of ex-CNN anchor covering protests
-
Djokovic 'pushed to the limit' in stunning late-night Sinner upset
-
Tunisia's famed blue-and-white village threatened after record rains
-
Top EU official voices 'shock' at Minneapolis violence
-
Kremlin says agreed to halt strikes on Kyiv until Sunday
-
Carrick calls for calm after flying start to Man Utd reign
-
Djokovic to meet Alcaraz in Melbourne final after five-set marathon
-
Italian officials to testify in trial over deadly migrant shipwreck
-
Iran says defence capabilities 'never' up for negotiation
-
UN appeals for more support for flood-hit Mozambicans
-
Lijnders urges Man City to pile pressure on Arsenal in title race
-
Fulham sign Man City winger Oscar Bobb
-
Strasbourg's Argentine striker Panichelli sets sights on PSG, World Cup
-
Jesus 'made love': Colombian president irks Christians with steamy claim
-
IAEA board meets over Ukraine nuclear safety concerns
-
Eurozone growth beats 2025 forecasts despite Trump woes
-
Israel to partially reopen Gaza's Rafah crossing on Sunday
-
Dutch PM-elect Jetten says not yet time to talk to Putin
-
Social media fuels surge in UK men seeking testosterone jabs
-
Forest face Fenerbahce, Celtic draw Stuttgart in Europa League play-offs
-
US speed queen Vonn crashes at Crans-Montana, one week before Olympics
-
Trump nominates former US Fed official as next central bank chief
-
Alcaraz defends controversial timeout after beaten Zverev fumes
-
New Dutch government pledges ongoing Ukraine support
-
Newcastle still coping with fallout from Isak exit, says Howe
-
Chad, France eye economic cooperation as they reset strained ties
-
Real Madrid to play Benfica, PSG face Monaco in Champions League play-offs
NYSE - LSE
Precidian Funds, Announces the Liquidation of AstraZeneca PLC ADRhedged
NEW YORK CITY, NEW YORK / ACCESS Newswire / January 30, 2026 / Precidian Funds today announced that AstraZeneca PLC ADRhedged™ (the "Series") will liquidate following AstraZeneca PLC's announcement that it will terminate its American Depositary Receipt ("ADR") program in connection with the implementation of a harmonized global listing structure and the direct listing of its ordinary shares on the New York Stock Exchange. This change is expected to become effective on or about February 2, 2026. As a result, all outstanding AstraZeneca PLC ADRs will be mandatorily cancelled and converted into ordinary shares on or around that date.
Due to the termination of the ADR program and the resulting inability of the Series to continue operating in accordance with its investment strategy, the Board of Trustees of Precidian ETFs Trust (the "Trust") has approved a plan of dissolution (the "Plan of Dissolution") for the Series.
Effective the evening of January 29, 2026, the Series ceased accepting creation and redemption orders. The Series will no longer engage in normal investment operations and will thereafter engage solely in activities necessary to wind up its affairs and complete an orderly liquidation.
Upon the mandatory cancellation of the AstraZeneca PLC ADRs, the Series is expected to receive AstraZeneca PLC ordinary shares on February 2, 2026, which the Series anticipates liquidating shortly thereafter. The Series expects to make a final cash distribution to shareholders on or about February 17, 2026, subject to the completion of all necessary administrative and operational processes.
The Series' shares will cease trading on NYSE Arca at the close of business on January 29, 2026.
If you have questions or need assistance, please contact your financial advisor directly or the Series toll-free at 844-954-5333.
SOURCE: Precidian Funds
View the original press release on ACCESS Newswire
O.Gutierrez--AT
